clopidogrel and Breast Neoplasms

clopidogrel has been researched along with Breast Neoplasms in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (50.00)	24.3611
2020's	4 (50.00)	2.80

Authors

Authors	Studies
Cairat, M; Dossus, L; Fournier, A; Hicks, B; Olesen, M; Pottegård, A	1
Arnachellen, D; Augustine, TN; Pillay, K; Xulu, KR	1
Al Rahmoun, M; Cairat, M; Dossus, L; Fournier, A; Gunter, MJ; Severi, G	1
Augustine, TN; Xulu, KR	1
Banach, J; Ekiert, M; Jarosz, J; Matkowski, R; Milczarek, M; Nowak, M; Papiernik, D; Porshneva, K; Psurski, M; Wietrzyk, J	1
Dhareshwar, J; Gulia, S; Gupta, S; Kannan, RA; Rodrigues, C; Vora, A	1
Eby, CS; Johnson, F; Lammers, PE; Naughton, MJ; Pluard, TJ; Roop, RP; Schneider, JG; Van Poznak, C; Weilbaecher, KN	1
Cardwell, CR; Hicks, BM; Hughes, C; Murray, LJ	1

Trials

1 trial(s) available for clopidogrel and Breast Neoplasms

Article	Year
A randomized phase II trial investigating the effect of platelet function inhibition on circulating tumor cells in patients with metastatic breast cancer. Clinical breast cancer, 2013, Volume: 13, Issue:6 Topics: Aspirin; Blood Platelets; Breast Neoplasms; Case-Control Studies; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prognosis; Ticlopidine; Treatment Outcome	2013

Article

Year

A randomized phase II trial investigating the effect of platelet function inhibition on circulating tumor cells in patients with metastatic breast cancer.

Clinical breast cancer, 2013, Volume: 13, Issue:6

Topics: Aspirin; Blood Platelets; Breast Neoplasms; Case-Control Studies; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prognosis; Ticlopidine; Treatment Outcome

2013

Other Studies

7 other study(ies) available for clopidogrel and Breast Neoplasms

Article	Year
Antiplatelet drugs and breast cancer risk in a large nationwide Danish case-control study. International journal of cancer, 2023, 04-01, Volume: 152, Issue:7 Topics: Aspirin; Breast Neoplasms; Case-Control Studies; Clopidogrel; Denmark; Dipyridamole; Female; Humans; Logistic Models; Middle Aged; Platelet Aggregation Inhibitors	2023
Breast Tumor Cells Evade the Cytotoxic Action of Anastrozole, Aspirin, and Clopidogrel Cocktail. Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada, 2023, 06-09, Volume: 29, Issue:3 Topics: Anastrozole; Animals; Antineoplastic Agents; Aspirin; Breast Neoplasms; Clopidogrel; Female; Humans; Mammary Neoplasms, Animal; Nitriles; Tamoxifen; Triazoles	2023
Antiplatelet Drug Use and Breast Cancer Risk in a Prospective Cohort of Postmenopausal Women. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2021, Volume: 30, Issue:4 Topics: Adult; Aged; Aspirin; Breast Neoplasms; Clopidogrel; Female; France; Humans; Middle Aged; Platelet Aggregation Inhibitors; Postmenopause; Prospective Studies; Risk Factors; Surveys and Questionnaires	2021
Antiplatelet Therapy Combined with Anastrozole Induces Features of Partial EMT in Breast Cancer Cells and Fails to Mitigate Breast-Cancer Induced Hypercoagulation. International journal of molecular sciences, 2021, Apr-16, Volume: 22, Issue:8 Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Aspirin; Blood Coagulation; Breast Neoplasms; Cells, Cultured; Clopidogrel; Drug Interactions; Epithelial-Mesenchymal Transition; Female; Humans; Imines; MCF-7 Cells; Platelet Aggregation Inhibitors; Pyridines; Thrombin; Thrombophilia	2021
Combination Therapy with DETA/NO and Clopidogrel Inhibits Metastasis in Murine Mammary Gland Cancer Models via Improved Vasoprotection. Molecular pharmaceutics, 2018, 11-05, Volume: 15, Issue:11 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Clopidogrel; Endothelium, Vascular; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Nitric Oxide Donors; Platelet Activation; Platelet Aggregation Inhibitors; Platelet-Rich Plasma; Triazenes	2018
Nocardial endocarditis in native aortic valve with nocardial sepsis in a case of breast cancer. BMJ case reports, 2019, Jul-11, Volume: 12, Issue:7 Topics: Amikacin; Anti-Bacterial Agents; Anticoagulants; Aortic Valve; Breast Neoplasms; Central Venous Catheters; Clopidogrel; Cough; Endocarditis, Bacterial; Fatigue; Female; Headache; Heart Valve Prosthesis Implantation; Humans; Meropenem; Middle Aged; Nocardia; Nocardia Infections; Platelet Aggregation Inhibitors; Radiography, Thoracic; Sepsis; Treatment Outcome; Warfarin	2019
Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients. Pharmacoepidemiology and drug safety, 2015, Volume: 24, Issue:8 Topics: Aged; Aged, 80 and over; Breast Neoplasms; Cause of Death; Clopidogrel; Colorectal Neoplasms; Databases, Factual; Drug Prescriptions; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Patient Safety; Pharmacoepidemiology; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prostatic Neoplasms; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome; United Kingdom	2015